A Controlled Human Rhinovirus Infection Study of 2-Deoxy-D-Glucose in Healthy Adults

Summary

2-DG-02 is a randomized, placebo-controlled, double-blind Phase 2 study to investigate the efficacy and safety of 2-Deoxy-D-Glucose as a pre-exposure prophylaxis using the rhinovirus challenge model in healthy study participants.

Timeline

Start

2024-04-02

Primary completion

2024-08-13

Completion

2024-08-13

Outcome

Outcome not reported

Stopped: “Re-calculated sample size”

Drugs

Indications